EUVIMEDEUVIMED entdecken
Crossref

Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma

Luna Picello, Mattia Dalle Nogare, Daniele Puggina, Cecilia Salvoro, Gianmaria Pennelli, Germano Gaudenzi, Silvia Carra, Monica Oldani, Davide Gentilini, Laura Fugazzola iD, Antongiulio Faggiano, Giovanni Vitale iD und 2 weitere

Endocrine-Related Cancer · 2025

DOI: 10.1530/erc-24-0344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2025. Verfasst von Luna Picello und 13 weiteren Autor:innen. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genetic component is thought to play an important role in the development of familial non-medullary thyroid carcinoma (fNMTC), but the involved molecular mechanisms and genes are poorly understood. The MAPK kinase cascade, particularly involving RAS and BRAF, is crucial in cancer development, with RIN1 emerging as a notable gene due to its differential expression across various tumor types. We identified a frameshift mutation (c.798delC: p.V267Sfs*83) in the RIN1 gene in a family with non-medullary thyroid cancer (NMTC) through whole-exome sequencing. Paraffin-embedded tumor tissues were analyzed to investigate the mutation’s characteristics and its potential implications within the thyroid cellular context. Functional assays and RNA sequencing using CRISPR/Cas9-edited Nthy-ori 3-1 thyroid cell line and xenograft zebrafish models confirmed the mutation effect and the putative RIN1 tumor suppressor role. The study revealed significant alterations in cellular behavior upon RIN1 knockout, including increased cell viability, proliferation and colony formation, alongside morphological changes indicative of epithelial–mesenchymal transition. Enhanced phosphorylation of ERK and AKT suggested MAPK pathway dysregulation following RIN1 depletion, supporting its potential tumor suppressive role. Phenotypic rescue experiments confirmed that reintroduction of wild-type RIN1 restored normal cellular behavior. RNA sequencing demonstrated differential gene expression between RIN1 −/− and control cells, particularly affecting pathways associated with cancer progression, closely resembled signatures specific to NMTC. This study provides compelling evidence supporting RIN1 as a tumor suppressor gene within thyroid cells. In addition, the findings highlight its potential significance as novel gene involved in FNMTC pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsIntracellular Signaling Peptides and ProteinsHumansAnimalsZebrafishFemaleMaleGenes, Tumor SuppressorCell Line, TumorMiddle AgedAdult

Stichwörter der Autor:innen

RIN1CRISPR/Cas9fNMTCthyroid cancertumor suppressor gene

Substanzen

Intracellular Signaling Peptides and ProteinsRIN1 protein, human

Autor:innen und Institutionen

ORCID-Profile: Laura Fugazzola, Giovanni Vitale, Gianluca Occhi

Zitieren

APA

Picello, L., Dalle Nogare, M., Puggina, D., Salvoro, C., Pennelli, G., Gaudenzi, G., Carra, S., Oldani, M., Gentilini, D., Fugazzola, L., Faggiano, A., Vitale, G., Occhi, G., & Vazza, G. (2025). Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-24-0344

Vancouver

Picello L, Dalle Nogare M, Puggina D, Salvoro C, Pennelli G, Gaudenzi G, et al. Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma. Endocrine-Related Cancer. 2025. doi:10.1530/erc-24-0344

BibTeX
@article{Picello2025,
  author = {Picello, Luna and Dalle Nogare, Mattia and Puggina, Daniele and Salvoro, Cecilia and Pennelli, Gianmaria and Gaudenzi, Germano and Carra, Silvia and Oldani, Monica and Gentilini, Davide and Fugazzola, Laura and Faggiano, Antongiulio and Vitale, Giovanni and Occhi, Gianluca and Vazza, Giovanni},
  title = {Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma},
  journal = {Endocrine-Related Cancer},
  year = {2025},
  doi = {10.1530/erc-24-0344}
}
Kostenlos starten →